Abstract
Pseudomonas aeruginosa (PA) is one of the most important respiratory pathogens in cystic fibrosis (CF) as chronic infection has a detrimental effect on morbidity and mortality [ [1] Emerson J. Rosenfeld M. McNamara S. Ramsey B. Gibson R.L. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002; 34: 91-100https://doi.org/10.1002/ppul.10127 Crossref PubMed Scopus (804) Google Scholar ]. The Leeds Criteria classify an individual's PA status as never (never isolated PA), free of infection (no PA growth for the previous 12 months but have previously isolated PA), intermittent infection (≤50% of samples in previous 12 months PA culture positive) or chronic infection (>50% of samples in previous 12 months PA culture positive) [ [2] Lee T.W.R. Brownlee K.G. Conway S.P. Denton M. Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003; 2: 29-34https://doi.org/10.1016/S1569-1993(02)00141-8 Abstract Full Text Full Text PDF PubMed Scopus (522) Google Scholar ]. It is vital that new isolates of PA are identified and eradication is attempted in a timely manner [ [3] Langton Hewer S.C. Smyth A.R Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev. 2009; CD004197https://doi.org/10.1002/14651858.CD004197.pub3 Crossref PubMed Scopus (103) Google Scholar ]. If this is not possible and chronic infection develops, the long-term use of anti-PA nebulised treatment improves lung function and reduces exacerbations [ [4] Smith S. Rowbotham N.J. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev. 2022; 11CD001021https://doi.org/10.1002/14651858.CD001021.pub4 Crossref Scopus (5) Google Scholar ]. Most clinical guidelines assume children who have chronic PA infection will continue to isolate PA and therefore stay on anti-PA treatment indefinitely.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.